Navigation Links
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Date:5/8/2008

in proprietary sales was primarily attributable to increased sales of SEASONIQUE extended cycle oral contraceptive, Plan B Over-the-Counter/Rx and the ParaGard(R) IUC, which more than offset the expected decrease in sales of our SEASONALE extended-cycle oral contraceptive, which has faced generic competition since September 2006, and decreased sales of Adderall(R) IR.

Alliance and Development Revenue

During the first quarter of 2008, the Company reported alliance and development revenue of $32 million, up from $25 million in the prior year period. The increase reflects higher royalties earned from the Company's agreement with Teva Pharmaceuticals on fexofenadine hydrochloride tablets, the generic version of Allegra(R) tablets, and higher reimbursements under its Shire development agreement, which more than offset lower reimbursements under its Adenovirus agreement with the Department of Defense, as the Company completed Phase III clinical trial for Adenovirus during the quarter.

Other Revenue

Other revenue primarily includes revenue from the Company's non-core operations, including the agrochemicals business and the diagnostic, disinfectants, dialysis and infusions (DDD&I) business. Other revenue totaled $11 million for the first quarter of 2008, compared to $12 million in the prior year period.

Margins

Generic: Margins in the generic segment were 50% for the first quarter of 2008, up from 44% in the prior year period. Last year's margins were negatively impacted by a charge of approximately $32 million related to the step-up of inventory acquired from PLIVA and sold in the period.

Proprietary: Margins in the proprietary segment were 68% for the first quarter of 2008, up from 66% in the prior year period.

Update on R&D Activities

Research and development expenses totaled $64 million for the first quarter of 2008, compared to $62 million in the prior year period.

Generic Products

At March 31
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
2. Dendreon Reports First Quarter 2008 Financial Results
3. Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results
4. Volcano Reports 24 Percent Increase in First Quarter Revenues; IVUS Disposable Revenues Increase 30 Percent
5. Oncothyreon Reports First Quarter 2008 Financial Results
6. iCAD Reports First Quarter 2008 Financial Results
7. AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results
8. American Oriental Bioengineering Reports First Quarter 2008 Financial Results
9. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
10. Onyx Pharmaceuticals Reports 2008 First Quarter Results
11. AtriCure Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... (PRWEB) , ... July 03, 2015 , ... Cuvettes have been used in countless labs ... catalog to find the cuvette they needed. As expected, this was a daunting and ... the wrong part because they were not able to navigate the complex catalog structure. , ...
(Date:7/2/2015)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today announced a litigation update. In ... Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, in the ... Virginia , the Court issued a ... claims in favor of the Defendants on the one ...
(Date:7/2/2015)... ... July 02, 2015 , ... Sleepless nights will become ... quality of sleep, launched its Indiegogo campaign on June 23. Sound sleepers and the ... technology makes it effortless to use, while the integration of the Bluetooth speaker, alarm ...
(Date:7/1/2015)... ... July 01, 2015 , ... It is now possible to ... single photon emission computed tomography (SPECT) according to researchers from Amen Clinics, ... over 20,000 brain scans and is believed to be the largest brain imaging study ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4
... July 25, 2011   ... articles on SciVerse ScienceDirect   ... information products and services, today announced the availability of an ... and mobile apps, on SciVerse Applications beta . The ...
... International, Inc. (Nasdaq: BDSI ) announced today ... of its Phase 3 clinical trial assessing the efficacy ... moderate to severe chronic pain, signifying completion of the ... very pleased to have brought to completion our Phase ...
... journal Nature Physics , the academics, who discovered ... in 2004, have revealed more about its electronic properties. ... already looking at ways to build devices such as ... from the creators of the material promises to accelerate ...
Cached Biology Technology:iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 2iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 3iSpeech® Develops Audio Reader for Elsevier's SciVerse Applications 4BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 2BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study 3Graphene's 'quantum leap' takes electronics a step closer 2
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
(Date:6/16/2015)... June 16, 2015  With the increasing number and ... a top concern. The recent compromise of Federal ... for strong authentication within government agencies. HYPR ... one-time password (OTP) authenticator, has been submitted for testing ... Level 3 validation for tamper proofing. ...
(Date:6/16/2015)... 16, 2015 Fingerprint Cards (FPC) raises ... it will amount to at least 340 MSEK to that ... rapid increase in market growth and orders received the revenue ... that revenue for 2015 will exceed 1,500 MSEK to an ... 2,200 MSEK. Due to receipt of orders of ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... be outside the box: A briefcase-sized kit is carried to ... The search is for microorganisms that could infect and kill ... If the equipment in the box finds the pathogen, ... and accurate are key. That,s what scientists plan to ...
... Institute of Technology (Caltech) and the University of California ... modeling and Caltech experimental data to show just how ... proteins. Their insights were recently published in the ... National Academy of Sciences (PNAS). The paper ...
... Graz, Austria Current research suggests that a new ... in archived tissue samples. The related report by ... in archival tissues from colorectal cancer patients using quantitative ... of The Journal of Molecular Diagnostics . ...
Cached Biology News:Portable kit may 1 day detect plant disease before disastrous outbreak 2Portable kit may 1 day detect plant disease before disastrous outbreak 3Caltech and UCSD researchers shed light on how proteins find their shapes 2New technique for cancer screening 2
Peptide Sequence: ovine COX-1 amino acids 272-282 (LMHYPRGIPPQ) To be used in conjunction with Cayman's COX-1 (ovine) polyclonal antiserum (Catalog No. 160108) to block protein-antibody complex f...
Anti-human VEGFR-1/Flt-1, clone Flt-1/EWI, Monoclonal Antibody...
Request Info...
Melanoma Antigen, Family C, 1 (MAGEC1) Rabbit anti-Human Polyclonal Antibody Immunogen: Synthetic peptide - KLH conjugated Family: New Recommended Storage: Long term: -20C; Short term: +4...
Biology Products: